香港股市 已收市

Arcellx, Inc. (ACLX)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
69.71-0.74 (-1.04%)
市場開市。 截至 10:21AM EDT。
全螢幕
交易股價資料並非來自所有市場
前收市價70.45
開市70.99
買盤69.39 x 200
賣出價69.99 x 100
今日波幅69.54 - 70.99
52 週波幅27.28 - 75.10
成交量11,179
平均成交量445,881
市值3.681B
Beta 值 (5 年,每月)0.02
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-1.47
業績公佈日
遠期股息及收益率無 (無)
除息日
1 年預測目標價79.08
  • Insider Monkey

    Insiders Are Dumping These 10 Healthcare Stocks

    In this article, we will take a detailed look at Insiders Are Dumping These 10 Healthcare Stocks. For a quick overview of such stocks, read our article Insiders Are Dumping These 5 Healthcare Stocks. Healthcare-focused investors were nervous when 2024 started, since election years usually do not bode well for the healthcare industry amid policy-related uncertainties. But healthcare stocks […]

  • Zacks

    Arcellx, Inc. (ACLX) Q4 Earnings and Revenues Surpass Estimates

    Arcellx, Inc. (ACLX) delivered earnings and revenue surprises of 166.67% and 163.52%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

  • InvestorPlace

    The 3 Biotech Stocks That Could Make Your February Unforgettable

    Following a hot year of M&A with biotech stocks, we’ll see more of the same in 2024 as drug makers look to build their pipelines ahead of a massive patent cliff. Between now and 2028, pharmaceutical giants stand to lose billions in revenue as blockbuster drug patents expire. According to EY analysts, the top 20 pharmaceutical giants could lose about $180 billion in sales by the end of the decade. It’s part of the reason Johnson & Johnson (NYSE:JNJ) said it would acquire antibody-drug conjugate (